BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11889437)

  • 1. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
    Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
    Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.
    Elssner A; Jaumann F; Dobmann S; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
    Transplantation; 2000 Jul; 70(2):362-7. PubMed ID: 10933164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
    Keane MP; Gomperts BN; Weigt S; Xue YY; Burdick MD; Nakamura H; Zisman DA; Ardehali A; Saggar R; Lynch JP; Hogaboam C; Kunkel SL; Lukacs NW; Ross DJ; Grusby MJ; Strieter RM; Belperio JA
    J Immunol; 2007 Jan; 178(1):511-9. PubMed ID: 17182591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.
    Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P
    J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload and nitric oxide-derived oxidative stress following lung transplantation.
    Reid D; Snell G; Ward C; Krishnaswamy R; Ward R; Zheng L; Williams T; Walters H
    J Heart Lung Transplant; 2001 Aug; 20(8):840-9. PubMed ID: 11502406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
    Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
    Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients. Marseille and Montreal Lung Transplantation Group.
    Magnan A; Mege JL; Reynaud M; Thomas P; Capo C; Garbe L; Meric B; Badier M; Bongrand P; Viard L
    Am J Respir Crit Care Med; 1994 Sep; 150(3):684-9. PubMed ID: 8087338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
    Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.